×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Jean-Emmanuel Kurtz (ICANS Strasbourg)

18:00
Introduction du partenariat avec le Cancéropôle
Rachel Groubet (Cancéropôle Est)
 
18:05
Les ADCs Anti-HER2, mécanismes d’action & de résistance et solutions d’après
Pr Sylvain Ladoire (CGFL Dijon)
 
18:20
Les inhibiteurs de tyrosine kinase Anti-HER2, classe thérapeutique à part entière, du mécanisme d’action à l’effet thérapeutique
Pr Thierry Petit (ICANS Strasbourg)
 
 
18:35
Cas clinique/Synthèse des stratégies thérapeutiques actuelles et perspectives
Dr Isabelle Desmoulins & Pr Sylvain Ladoire (CGFL Dijon)
 
18:50
Débat/Discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-10-13
Last update : 2022-10-14

Suggestions

Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 19th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, November 19th 2024 from 09am to 10:30am (GMT+1)
New York : Tuesday, November 19th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, November 19th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, November 19th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, November 19th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 19th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, November 20th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, November 20th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, November 20th 2024 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, November 20th 2024 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, November 20th 2024 from 05am to 06:30am (GMT+1)

Cancer du sein métastatique RH+/HER2- :

individualisation du traitement en 1ère et 2ème ligne

Share
Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Honolulu : Thursday, March 10th 2022 from 08am to 10am (GMT+1)
San Francisco : Thursday, March 10th 2022 from 10am to 12pm (GMT+1)
New York : Thursday, March 10th 2022 from 01pm to 03pm (GMT+1)
Buenos Aires : Thursday, March 10th 2022 from 03pm to 05pm (GMT+1)
London / Dublin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
Paris / Berlin : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Istanbul : Thursday, March 10th 2022 from 08pm to 10pm (GMT+1)
Moscou / Dubaï : Thursday, March 10th 2022 from 10pm to 12am (GMT+1)
Bangkok : Friday, March 11th 2022 from 01am to 03am (GMT+1)
Shanghai : Friday, March 11th 2022 from 02am to 04am (GMT+1)
Tokyo : Friday, March 11th 2022 from 03am to 05am (GMT+1)
Sydney : Friday, March 11th 2022 from 04am to 06am (GMT+1)
Wellington : Friday, March 11th 2022 from 06am to 08am (GMT+1)

Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

Share
Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
Honolulu : Friday, February 9th 2024 from 06:30am to 08am (GMT+1)
San Francisco : Friday, February 9th 2024 from 08:30am to 10am (GMT+1)
New York : Friday, February 9th 2024 from 11:30am to 01pm (GMT+1)
Buenos Aires : Friday, February 9th 2024 from 01:30pm to 03pm (GMT+1)
London / Dublin : Friday, February 9th 2024 from 04:30pm to 06pm (GMT+1)
Paris / Berlin : Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
Istanbul : Friday, February 9th 2024 from 06:30pm to 08pm (GMT+1)
Moscou / Dubaï : Friday, February 9th 2024 from 08:30pm to 10pm (GMT+1)
Bangkok : Friday, February 9th 2024 from 11:30pm to 01am (GMT+1)
Shanghai : Saturday, February 10th 2024 from 12:30am to 02am (GMT+1)
Tokyo : Saturday, February 10th 2024 from 01:30am to 03am (GMT+1)
Sydney : Saturday, February 10th 2024 from 02:30am to 04am (GMT+1)
Wellington : Saturday, February 10th 2024 from 04:30am to 06am (GMT+1)

Le réseau FEM-NET, position du problème pour les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, May 14th 2024 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, May 14th 2024 from 10am to 11:30am (GMT+2)
New York : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, May 14th 2024 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, May 14th 2024 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, May 15th 2024 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, May 15th 2024 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, May 15th 2024 from 06am to 07:30am (GMT+2)

Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Scroll Up